CompletedNCT05281640
Official study titlePsychological Interventions for Complex PTSD And Schizophrenia-Spectrum Disorder: PICASSO Trial
This study has finished and is no longer accepting participants.
Multiple locations, including EdinburghSchizophrenia, PTSDBehavioural studyAges 18–65
- Countries
- United Kingdom
- Sponsor
- Edinburgh Napier University
CompletedNCT03983018
Official study titleRituximab - Immunotherapy for Schizophrenia Spectrum Disorder in Adults: An Open Pilot Study
This study has finished and is no longer accepting participants.
In ÖrebroSchizophreniaMedication studyAges 18–40
- Countries
- Sweden
- Sponsor
- Region Örebro County
WithdrawnNCT05389345
Official study titleEffects of Adding Transcranial Direct Current Stimulation to Executive Function Training for Schizophrenia-spectrum Disorders - a Randomized Control Trial
This study was withdrawn before enrollment.
In WhitbySchizophreniaBehavioural studyAges 18–65
- Countries
- Canada
- Sponsor
- University of Toronto
CompletedEUCTR 2014-000757-36
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In RomaniaSchizophreniaHistorical research record
- Countries
- Romania
- Sponsor
- Clinirx Tangent Research
CompletedEUCTR 2005-002304-41
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In DenmarkSchizophreniaHistorical research record
- Countries
- United Kingdom, Denmark, Finland, + 3 others
- Sponsor
- Janssen-Cilag EMEA Medical Affairs
Recruitment unclearEUCTR 2021-001337-40
Official study titleA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO DETERMINE EFFICACY AND SAFETY OF BXCL501 IN AGITATION ASSOCIATED WITH PEDIATRIC SCHIZOPHRENIA AND BIPOLAR DISORDER
Original registry wording; source language not specified.
Current recruitment status is unconfirmed.
This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.
In SpainSchizophrenia, BipolarityHistorical research record
- Countries
- Spain
- Sponsor
- BioXcel Therapeutics, Inc.
Recruitment unclearEUCTR 2014-003008-53
Current recruitment status is unconfirmed.
This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.
In NetherlandsSchizophreniaHistorical research record
- Countries
- Netherlands
- Sponsor
- University Medical Center Utrecht
Not recruitingEUCTR 2004-001376-39
This study isn't currently recruiting.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Czech RepublicSchizophreniaHistorical research record
- Countries
- Czechia, Germany, Spain
- Sponsor
- NV Organon
Not recruitingEUCTR 2020-004752-16
This study isn't currently recruiting.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaSchizophreniaHistorical research record
- Countries
- Bulgaria, Croatia, Poland, + 1 other
- Sponsor
- F. Hoffmann-La Roche Ltd
Not recruitingISRCTN06332944
This study isn't currently recruiting.
In NetherlandsSchizophreniaResearch study
- Countries
- Netherlands
- Sponsor
- The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
CompletedNCT00222794
Official study titleA Randomized, Parallel Group, Double Blind, Placebo Controlled, Clinical Trial of Augmentation With Atomoxetine for the Treatment of Negative Symptoms in Patients With Schizophrenia and Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In PittsburghSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- University of Pittsburgh
CompletedNCT00253110
Official study titleA Comparison of Risperidone and Haloperidol for Prevention of Relapse in Subjects With Schizophrenia and Schizoaffective Disorders
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–65
- Countries
- Sponsor
- Janssen, LP